Search

Your search keyword '"Stuart,David"' showing total 438 results

Search Constraints

Start Over You searched for: Author "Stuart,David" Remove constraint Author: "Stuart,David" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
438 results on '"Stuart,David"'

Search Results

1. Sample Preparation and Data Collection for High-Speed Fixed-Target Serial Femtosecond Crystallography

3. Accelerating Inhibitor Discovery With A Deep Generative Foundation Model: Validation for SARS-CoV-2 Drug Targets

4. The Forward Physics Facility at the High-Luminosity LHC

6. Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam

7. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

8. A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity

13. A multi-country analysis of COVID-19 hospitalizations by vaccination status

15. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

17. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

18. Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses

19. Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region

20. A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75

21. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

23. Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particles

24. Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

32. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

33. Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.

34. A pipeline for identification of causal mutations in barley identifies Xantha-j as the chlorophyll synthase gene.

36. Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection

37. The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86

38. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

42. The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86

43. Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection

44. Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.

45. Synthesis of Alkyl Aryl Ethers by O-Arylation of Alcohols with Diaryliodonium Salts: Scope, Limitations, and Mechanism.

46. Changing the Reactive Coatings Market with Graphite

47. Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection

48. Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study

49. COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance

50. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses

Catalog

Books, media, physical & digital resources